Hyper IgM syndrome associated with defective CD40-mediated B cell activation

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• X-linked hyper IgM syndrome is often linked to CD40 ligand gene defects.
• Understanding the molecular basis of this syndrome is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate the genetic and molecular causes of X-linked hyper IgM syndrome in patients with suspected defects.
• To differentiate between CD40 ligand deficiencies and B cell signaling defects.

Main Methods:

• Evaluated 17 male patients with suspected X-linked hyper IgM syndrome.
• Assessed T cell binding to a soluble CD40 construct.
• Sequenced CD40 ligand cDNA.
• Stimulated peripheral blood lymphocytes with anti-CD40 and IL4 to examine B cell activation markers (CD25, CD23) and IgE secretion.

Main Results:

• 13 of 17 patients had mutations in the CD40 ligand gene, with T cells failing to bind CD40.
• The remaining 4 patients had normal CD40 ligand but showed defective B cell responses to anti-CD40 stimulation, specifically reduced IgE secretion and CD25/CD23 expression.
• B cell activation was not globally impaired, as IL4 induced normal CD23 and CD25 expression.

Conclusions:

• X-linked hyper IgM syndrome can arise from either T cell CD40 ligand expression defects or B cell CD40-mediated signal transduction abnormalities.
• Identifies two distinct pathogenic mechanisms contributing to hyper IgM syndrome.